Feifei Guo

4.6k total citations · 1 hit paper
95 papers, 2.7k citations indexed

About

Feifei Guo is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Feifei Guo has authored 95 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 12 papers in Pharmacology and 11 papers in Oncology. Recurrent topics in Feifei Guo's work include Computational Drug Discovery Methods (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Bioinformatics and Genomic Networks (8 papers). Feifei Guo is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Bioinformatics and Genomic Networks (8 papers). Feifei Guo collaborates with scholars based in China, United States and Australia. Feifei Guo's co-authors include Fuchu He, Zhongyang Liu, Dong Li, Lihong Diao, Longxian Lv, Daiqiong Fang, Ding Shi, Jiangyong Gu, Lanjuan Li and Xinlei Zhang and has published in prestigious journals such as Nature Communications, Nano Letters and Bioinformatics.

In The Last Decade

Feifei Guo

92 papers receiving 2.7k citations

Hit Papers

BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular ... 2016 2026 2019 2022 2016 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine
    2016 639 citations Zhongyang Liu, Feifei Guo et al. Scientific Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Guo China 22 1.5k 423 365 300 285 95 2.7k
Xianglu Rong China 27 1.5k 1.0× 518 1.2× 438 1.2× 187 0.6× 249 0.9× 76 3.2k
Peibo Li China 29 1.2k 0.8× 164 0.4× 388 1.1× 140 0.5× 351 1.2× 112 2.6k
Shi-Bing Su China 30 1.3k 0.8× 538 1.3× 563 1.5× 540 1.8× 428 1.5× 125 2.9k
Chi‐Cheng Lu Taiwan 42 2.7k 1.8× 602 1.4× 420 1.2× 575 1.9× 308 1.1× 140 5.0k
Jung‐Hyun Shim South Korea 34 2.1k 1.4× 274 0.6× 627 1.7× 639 2.1× 192 0.7× 193 4.0k
Kishore Banik India 35 2.0k 1.3× 195 0.5× 519 1.4× 413 1.4× 258 0.9× 46 3.7k
Halagowder Devaraj India 31 1.2k 0.8× 256 0.6× 238 0.7× 321 1.1× 173 0.6× 108 2.8k
Tze‐chen Hsieh United States 33 1.7k 1.1× 206 0.5× 254 0.7× 356 1.2× 141 0.5× 72 3.3k

Countries citing papers authored by Feifei Guo

Since Specialization
Citations

This map shows the geographic impact of Feifei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Guo more than expected).

Fields of papers citing papers by Feifei Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Guo. The network helps show where Feifei Guo may publish in the future.

Co-authorship network of co-authors of Feifei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Guo. A scholar is included among the top collaborators of Feifei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Guo. Feifei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adlerz, Katrina, Feifei Guo, Yisheng Li, et al.. (2025). CAR-T Rapid Manufacturing: Implications on Product and Analytical Testing. Cytotherapy. 27(5). S161–S161.
2.
Li, Xiong, et al.. (2024). Leukocyte Platelet‐Rich Plasma‐Derived Exosomes Restrained Macrophages Viability and Induced Apoptosis, NO Generation, and M1 Polarization. Immunity Inflammation and Disease. 12(11). e70064–e70064. 5 indexed citations
3.
Guo, Feifei, Yi Zhang, Ling Bai, & Jiuwei Cui. (2023). Natural killer cell therapy targeting cancer stem cells: Old wine in a new bottle. Cancer Letters. 570. 216328–216328. 15 indexed citations
4.
Guo, Feifei, et al.. (2023). Triglyceride‐glucose index (TyG index) and endometrial carcinoma risk: A retrospective cohort study. International Journal of Gynecology & Obstetrics. 164(1). 298–304. 12 indexed citations
5.
Guo, Feifei, Tong Li, Xue Zhang, et al.. (2023). Electrochemical detection of the oxidative damage of a potential pyrimido[5,4-g]pteridine-derived antitumor agent toward DNA. Analytical and Bioanalytical Chemistry. 415(12). 2249–2260. 1 indexed citations
6.
Li, Tong, Feifei Guo, Zhihao Xu, et al.. (2023). Se nanoparticles-loaded and Mo-doped iron phthalocyanine nanorods as photoresponsive nanozyme for efficient synergistic sterilization. Materials Letters. 346. 134565–134565. 3 indexed citations
7.
Li, Tong, Feifei Guo, Ping Sun, et al.. (2023). Electrochemical detection of genetic damage caused by the interaction of novel bifunctional anthraquinone-temozolomide antitumor hybrids with DNA modified electrode. Journal of Pharmaceutical and Biomedical Analysis. 231. 115410–115410. 2 indexed citations
8.
Yang, Yang, Caifeng Chen, Feifei Guo, et al.. (2023). In vitro and in vivo antitumor activities of Ru and Cu complexes with terpyridine derivatives as ligands. Journal of Inorganic Biochemistry. 246. 112284–112284. 2 indexed citations
9.
Liu, Zhongyang, Honglei Li, Zhaoyu Jin, et al.. (2022). Exploration of Target Spaces in the Human Genome for Protein and Peptide Drugs. Genomics Proteomics & Bioinformatics. 20(4). 780–794. 2 indexed citations
10.
Guo, Feifei, et al.. (2021). Prevalence and risk factors of frailty among people in rural areas: a systematic review and meta-analysis. BMJ Open. 11(4). e043494–e043494. 32 indexed citations
11.
Guo, Feifei, Lingyu Li, Yang Wang, Ji‐Fan Hu, & Jiuwei Cui. (2021). Long noncoding RNA: A resident staff of genomic instability regulation in tumorigenesis. Cancer Letters. 503. 103–109. 8 indexed citations
12.
Bao, Lei, Changfu Hao, Juan Wang, et al.. (2021). In vitro co-culture model of human monocyte-derived dendritic cells and T cells to evaluate the sensitization of dinitrochlorobenzene. Ecotoxicology and Environmental Safety. 220. 112331–112331. 4 indexed citations
13.
Guo, Feifei & Jiuwei Cui. (2020). Anti-angiogenesis: Opening a new window for immunotherapy. Life Sciences. 378. 118163–118163. 42 indexed citations
14.
Wang, Ping, Jiaqi Zhang, Feifei Guo, et al.. (2019). Lipopolysaccharide worsens the prognosis of experimental cerebral ischemia via interferon gamma-induced protein 10 recruit in the acute stage. BMC Neuroscience. 20(1). 64–64. 17 indexed citations
15.
Chen, Lixia, Feifei Guo, Yang Cao, et al.. (2019). Effects of epigallocatechin-3-gallate on the HMGB1/RAGE pathway in PM2.5-exposed asthmatic rats. Biochemical and Biophysical Research Communications. 513(4). 898–903. 15 indexed citations
16.
17.
18.
Li, Yang, Ping Xie, Lu Liang, et al.. (2017). An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nature Communications. 8(1). 347–347. 173 indexed citations
19.
Zhang, Jingjing, Feifei Guo, Junying Wei, et al.. (2017). An integrated approach to identify critical transcription factors in the protection against hydrogen peroxide-induced oxidative stress by Danhong injection. Free Radical Biology and Medicine. 112. 480–493. 17 indexed citations
20.
Shi, Ding, Longxian Lv, Daiqiong Fang, et al.. (2017). Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. Scientific Reports. 7(1). 6927–6927. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xianglu Rong Breakdown of academic impact, for papers by Peibo Li Breakdown of academic impact, for papers by Shi-Bing Su Breakdown of academic impact, for papers by Chi‐Cheng Lu Breakdown of academic impact, for papers by Jung‐Hyun Shim Breakdown of academic impact, for papers by Kishore Banik Breakdown of academic impact, for papers by Halagowder Devaraj Breakdown of academic impact, for papers by Tze‐chen Hsieh
Rankless by CCL
2026